InvestorsHub Logo

Back2Deuce

03/01/20 7:01 PM

#249427 RE: sharinky #249420

Yep, I tend to agree with your assessment and am cautiously optimistic we get a very nice run on news of a trial win.

Also recall that many were calling for a drop in the stock upon release of the AdCom briefing from the FDA. Some were even waiting on the sidelines to buy in after the release, expecting a drop in share price so they could buy in much cheaper before the anticipated AdCom recommendation of approval. Instead, the stock made a nice gap higher at the open that morning due to the reassuring content in the briefs.